DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $423,000 | -66.4% | 19,215 | -72.6% | 0.00% | -82.4% |
| Q3 2020 | $1,260,000 | +213.4% | 70,016 | +342.0% | 0.02% | +142.9% |
| Q2 2020 | $402,000 | -60.2% | 15,840 | -71.2% | 0.01% | -73.1% |
| Q1 2020 | $1,011,000 | -68.6% | 55,045 | -62.3% | 0.03% | +36.8% |
| Q4 2019 | $3,219,000 | +421.7% | 146,123 | +240.0% | 0.02% | +216.7% |
| Q3 2019 | $617,000 | +60.7% | 42,976 | +76.5% | 0.01% | +50.0% |
| Q2 2019 | $384,000 | +17.1% | 24,353 | -20.7% | 0.00% | 0.0% |
| Q4 2018 | $328,000 | -56.7% | 30,721 | -38.1% | 0.00% | -55.6% |
| Q3 2018 | $757,000 | +1444.9% | 49,593 | +204.3% | 0.01% | +200.0% |
| Q2 2016 | $49,000 | – | 16,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |